Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350
Q3 FY26 results · Oct–Dec 2025
Dr. Agarwal's Health Care reported revenue from operations of ₹529.86 crore (up 23.0% from Q3 FY25) and net profit of ₹43.63 crore (up 54.5% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 529.86 | 430.72 | +23.0% | 498.69 | +6.3% |
| Other income | 10.54 | 12.71 | −17.1% | 7.93 | +32.9% |
| Total income | 540.40 | 443.43 | +21.9% | 506.62 | +6.7% |
| Profit before tax | 64.76 | 40.99 | +58.0% | 53.66 | +20.7% |
| Net profit for the period | 43.63 | 28.24 | +54.5% | 36.49 | +19.6% |
| Attributable to shareholders of the company | 33.74 | 22.34 | +51.0% | 29.69 | +13.6% |
| EPS, basic (₹) | 1.07 | 0.73 | +47.4% | 0.94 | +13.8% |
| Net margin (%) | 8.2 | 6.6 | 7.3 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 334.84 | 267.93 | +25.0% | 308.98 | +8.4% |
| Other income | 7.11 | 10.48 | −32.2% | 6.81 | +4.4% |
| Total income | 341.95 | 278.41 | +22.8% | 315.79 | +8.3% |
| Profit before tax | 20.40 | 12.10 | +68.6% | 9.56 | +113.4% |
| Net profit for the period | 14.06 | 7.62 | +84.5% | 4.68 | +200.4% |
| EPS, basic (₹) | 0.44 | 0.25 | not comparable | 0.15 | +193.3% |
| Net margin (%) | 4.2 | 2.8 | 1.5 |
Consolidated
- Filed with BSE
- 03 Feb 2026, 20:36 IST
- Board meeting
- 03 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Feb 2026, 20:36 IST
- Board meeting
- 03 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE